REFERENCES
- Bartalena L, Pinchera A, Marcocci C. Management of Graves' Ophthalmopathy: Reality and Perspectives. Endocr Rev. 2000; 21(2)168–199, [PUBMED], [INFOTRIEVE], [CSA]
- Friedrichs N, Eis-Hubinger A, Heim A, et al. Acute adenoviral infection of a graft by serotype 35 following renal transplantation. Pathol Res Pract. 2003; 199(8)565–570, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gerding M N, Prummel M F, Kalmann R, Koornneef L, Wiersinga W M. The use of colour slides in the assessment of changes in soft-tissue involvement in Graves' ophthalmopathy. J Endocrinol Invest. 1998; 21(7)459–462, [PUBMED], [INFOTRIEVE], [CSA]
- Kahaly G, Diaz M, Just M, Beyer J, Lieb W. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy. Thyroid. 1995; 5(2)107–111, [PUBMED], [INFOTRIEVE], [CSA]
- Krassas G, Dumas A. Octreoscan in Graves' ophthalmopathy. Thyroid. 1997; 7(5)805–806, [PUBMED], [INFOTRIEVE], [CSA]
- Laitt R D, Hoh B, Wakeley C, et al. The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease. Br J Radiol. 1994; 67(795)244–247, [PUBMED], [INFOTRIEVE], [CSA]
- Mourits M P, Prummel M F, Wiersinga W M, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol. 1997; 47(1)9–14, [CROSSREF], [CSA]
- Stuart-Harris C. The epidemiology and clinical presentation of herpes virus infections. J Antimicrob Chemother. 1983; 12(Suppl B)1–8, [PUBMED], [INFOTRIEVE], [CSA]
- Utech C I, Khatibnia U, Winter P F, Wulle K G. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid. 1995; 5(3)185–193, [PUBMED], [INFOTRIEVE], [CSA]
- Wiersinga W M, Prummel M F. Graves' ophthalmopathy: a rational approach to treatment. Trends Endocrinol Metab. 2002; 13(7)280–287, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]